The peptide category, sourced.
Ten sourced articles on the business and regulatory side of peptides: platform policy, FDA compounding, research-use framing, FTC substantiation, certification, the GLP-1 timeline, AI crawler policy, the supplement question, and the production method behind all of it.
Every article cites the primary record, with dates: FDA pages and warning letters, platform policy documents, and Google's own documentation. No biology, no product claims, and no legal advice. This library exists because in a vertical where paid advertising is closed by written policy, being the most accurate source in the category is the growth strategy.
Why Peptide Brands Cannot Advertise on Google or Meta
Both platforms close the paid channel in writing. The exact policy language, quoted and linked, and what growth looks like without it.
FDAFDA's Compounding Categories, Explained for Peptide Businesses
Many of the market's best-known peptides sit in category 2 of FDA's interim policy. What that classification says, in the agency's own words, and what it does not.
EnforcementWhat “Research Use Only” Does and Does Not Protect
FDA's December 2024 letters to peptide sellers are plain: the label does not decide how a product is classified. The marketing does.
Search qualityYMYL and E-E-A-T: The Bar Google Sets for Peptide Content
Health-adjacent content competes under Google's strictest quality standards. What its own documentation establishes, and what it takes to meet it.
CertificationLegitScript Certification, Explained
The one credential Meta names for prescription promotion and payment processors read. Who it is for, and the honest part about who it will not help.
FTCThe FTC's Substantiation Standard, and What It Means for Peptide Marketing
Every objective health claim needs evidence before it runs, express or implied, testimonials included. The standard, quoted from the guidance.
Enforcement timelineThe GLP-1 Compounding Shift: What Ended, When, and What It Means
The shortage-era allowance ended on published dates, the 503B door is proposed shut, and the warning letters landed mid-sequence. The timeline, sourced.
AI searchAI Crawler Policy: robots.txt, Google-Extended, and llms.txt
The switches that decide whether AI systems may cite you, from the primary documentation, plus the injected-rules failure we found on our own site.
ClassificationIs a Peptide a Dietary Supplement? Who Decides
Supplement is a statutory classification, not a marketing word. FDA's definition quoted, and why the standard disclaimer does not rescue the copy around it.
The methodThe Compliance-First Content Playbook, Written Down
How this library was made: facts before copy, claims about documents, dates on everything, and the validator that enforces it. The capstone.
Findable, and defensible.
Start with a free data audit. We will show you where your peptide brand ranks, where the compliance risks sit in your current content, and what it takes to grow branded search. No commitment.
Get Ranked Free